{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:47:29Z","timestamp":1769240849109,"version":"3.49.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,2]],"date-time":"2012-03-02T00:00:00Z","timestamp":1330646400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0032664","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T16:08:23Z","timestamp":1330963703000},"page":"e32664","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["CSF Concentrations of cAMP and cGMP Are Lower in Patients with Creutzfeldt-Jakob Disease but Not Parkinson's Disease and Amyotrophic Lateral Sclerosis"],"prefix":"10.1371","volume":"7","author":[{"given":"Patrick","family":"Oeckl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Steinacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Jesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans A.","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert C.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Ferger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,3,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrm911","article-title":"Cyclic nucleotide research \u2013 still expanding after half a century.","volume":"3","author":"JA Beavo","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1007\/s11064-008-9681-1","article-title":"Regulation and function of cyclic GMP-mediated pathways in glial cells.","volume":"33","author":"MA Baltrons","year":"2008","journal-title":"Neurochem Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2010.05.004","article-title":"CXCR4-mediated glutamate exocytosis from astrocytes.","volume":"224","author":"C Cali","year":"2010","journal-title":"J Neuroimmunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1460-9568.2008.06387.x","article-title":"Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms.","volume":"28","author":"M Giorgi","year":"2008","journal-title":"Eur J Neurosci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0022-3565(25)39507-8","article-title":"Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson&apos;s disease.","volume":"267","author":"MA Hossain","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0006-8993(98)01186-X","article-title":"Degeneration of NO-synthesizing cerebrocortical neurons in transgenic mice expressing mutated superoxide dismutase is not due to elevated nitric oxide levels.","volume":"816","author":"MC Aguila","year":"1999","journal-title":"Brain Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis.","volume":"344","author":"LP Rowland","year":"2001","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.nbd.2004.07.022","article-title":"Reduced expression of NO-sensitive guanylyl cyclase in reactive astrocytes of Alzheimer disease, Creutzfeldt-Jakob disease, and multiple sclerosis brains.","volume":"17","author":"MA Baltrons","year":"2004","journal-title":"Neurobiol Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/187152409787601950","article-title":"Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy.","volume":"9","author":"I Dupiereux","year":"2009","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(08)70293-X","article-title":"Biomarkers in amyotrophic lateral sclerosis.","volume":"8","author":"MR Turner","year":"2009","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s00415-010-5876-x","article-title":"Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases.","volume":"258","author":"S Jesse","year":"2011","journal-title":"J Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2217\/bmm.10.84","article-title":"Problems associated with fluid biomarkers for Parkinson&apos;s disease.","volume":"4","author":"J Nyhlen","year":"2010","journal-title":"Biomark Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1755-5949.2008.00064.x","article-title":"Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review.","volume":"15","author":"S Jesse","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.","volume":"10","author":"B Mollenhauer","year":"2011","journal-title":"Lancet Neurol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","article-title":"Axonal damage markers in cerebrospinal fluid are increased in ALS.","volume":"66","author":"J Brettschneider","year":"2006","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neulet.2007.02.002","article-title":"Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.","volume":"416","author":"J Brettschneider","year":"2007","journal-title":"Neurosci Lett"},{"key":"ref18","year":"1998"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archneur.60.6.813","article-title":"Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.","volume":"60","author":"MD Geschwind","year":"2003","journal-title":"Arch Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","article-title":"Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.","volume":"58","author":"M Otto","year":"2002","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-2010-100030","article-title":"ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients.","volume":"22","author":"P Steinacker","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/pmic.200900246","article-title":"Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease.","volume":"10","author":"P Steinacker","year":"2010","journal-title":"Proteomics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.","volume":"17","author":"R Atarashi","year":"2011","journal-title":"Nat Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1198\/000313007X247643","article-title":"Peirce, Youden, and Receiver Operating Characteristic Curves.","volume":"61","author":"SG Baker","year":"2007","journal-title":"Am Stat"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/01.WNL.0000113764.35026.EF","article-title":"Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.","volume":"62","author":"M Otto","year":"2004","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.","volume":"47","author":"IG McKeith","year":"1996","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jneumeth.2011.09.032","article-title":"Simultaneous LC-MS\/MS analysis of the biomarkers cAMP and cGMP in plasma, CSF and brain tissue.","volume":"203","author":"P Oeckl","year":"2011","journal-title":"J Neurosci Methods"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000116124","article-title":"Cyclic nucleotides in cerebrospinal fluid of drug-free Parkinson patients.","volume":"27","author":"N Covickovic-Sternic","year":"1987","journal-title":"Eur Neurol"},{"key":"ref29","first-page":"431","article-title":"Analysis of neurotransmitter metabolites and adenosine 3\u2032,5\u2032-monophosphate in the CSF of patients with extrapyramidal motor disorders.","volume":"40","author":"H Cramer","year":"1984","journal-title":"Adv Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01276464","article-title":"Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases.","volume":"100","author":"M Ikeda","year":"1995","journal-title":"J Neural Transm Gen Sect"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00313327","article-title":"Cyclic adenosine 3\u2032,5\u2032 monophosphate in cerebrospinal fluid of multiple sclerosis patients.","volume":"225","author":"E Maida","year":"1981","journal-title":"J Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.39.12.1186","article-title":"Studies on cyclic AMP in different compartments of cerebrospinal fluid.","volume":"39","author":"D Tsang","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archneur.1973.00490270079014","article-title":"Adenosine 3\u2032,5\u2032-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease.","volume":"29","author":"H Cramer","year":"1973","journal-title":"Arch Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jchromb.2008.12.063","article-title":"Development and validation of an LC-MS\/MS method for quantification of cyclic guanosine 3\u2032,5\u2032-monophosphate (cGMP) in clinical applications: a comparison with a EIA method.","volume":"877","author":"Y Zhang","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-510X(97)00267-0","article-title":"Cerebrospinal fluid cyclic guanosine 3\u20325\u2032 monophosphate levels in Parkinson&apos;s disease.","volume":"155","author":"JA Navarro","year":"1998","journal-title":"J Neurol Sci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1212\/WNL.36.1.89","article-title":"CSF cyclic nucleotides and somatostatin in Parkinson&apos;s disease.","volume":"36","author":"L Volicer","year":"1986","journal-title":"Neurology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00427396","article-title":"The effect of L-dopa and propranolol on human CSF cyclic nucleotides.","volume":"58","author":"RH Belmaker","year":"1978","journal-title":"Psychopharmacology (Berl)"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.brainresbull.2009.12.004","article-title":"Selective D1 agonism but not D2 antagonism is reflected in cAMP and cGMP levels in rat CSF.","volume":"81","author":"A Torremans","year":"2010","journal-title":"Brain Res Bull"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0006-8993(99)01981-2","article-title":"Increased cerebrospinal fluid cAMP levels in Alzheimer&apos;s disease.","volume":"846","author":"M Martinez","year":"1999","journal-title":"Brain Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0306-4530(81)90009-3","article-title":"CSF Vasopressin and cyclic nucleotide concentrations in senile dementia.","volume":"6","author":"M Tsuji","year":"1981","journal-title":"Psychoneuroendocrinology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/geronj\/40.6.708","article-title":"Catecholamine metabolites and cyclic nucleotides in cerebrospinal fluid in dementia of Alzheimer type.","volume":"40","author":"L Volicer","year":"1985","journal-title":"J Gerontol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00702-003-0086-7","article-title":"Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis.","volume":"111","author":"J Ilzecka","year":"2004","journal-title":"J Neural Transm"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cll.2009.11.002","article-title":"Prion diseases.","volume":"30","author":"S Venneti","year":"2010","journal-title":"Clin Lab Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/thx.36.11.823","article-title":"Plasma cyclic nucleotide levels in exercise-induced asthma.","volume":"36","author":"JP Hartley","year":"1981","journal-title":"Thorax"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1531-8249(200009)48:3<395::AID-ANA18>3.0.CO;2-A","article-title":"An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients.","volume":"48","author":"K Kenney","year":"2000","journal-title":"Ann Neurol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s004150050145","article-title":"S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.","volume":"244","author":"M Otto","year":"1997","journal-title":"J Neurol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e16804","DOI":"10.1371\/journal.pone.0016804","article-title":"Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders.","volume":"6","author":"A Singh","year":"2011","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0032664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T10:54:13Z","timestamp":1742640853000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0032664"}},"subtitle":[],"editor":[{"given":"Christoph","family":"Kleinschnitz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,2]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0032664","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,2]]}}}